-

Shareholder Alert: Robbins LLP informs Shareholders of Class Action Against Okta, Inc.

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Okta, Inc. (NASDAQ: OKTA) securities between March 5, 2021 and March 22, 2022, for violations of the Securities Exchange Act of 1934. Okta provides identity solutions for enterprises, small and medium-sized business, universities, non-profits, and government agencies in the U.S. and internationally. Following its merger with Auth0, Inc. on May 3, 2021, Okta began providing additional Auth0 products related to cybersecurity and login solutions.

If you would like more information about Okta, Inc.'s misconduct, click here.

What is this Case About: Okta, Inc. (OKTA) Failed to Disclose Security Breach

According to the complaint, during the class period, defendants made false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, defendants failed to disclose that Okta had inadequate cybersecurity controls, and as a result, its systems were vulnerable to data breaches. Okta ultimately did experience a data breach caused by a hacking group, which potentially affected hundreds of Okta customers. Okta initially did not disclose and subsequently downplayed the severity of the data breach. When Okta revealed the occurrence of the breach, Okta's stock price fell $2.98 per share, to close at $166.43 per share on March 22, 2022. Then, Raymond James downgraded Okta from "strong buy" to "market perform," noting, among other things, that "[w]hile partners were willing to trust Okta's track record, the handling of its latest security incident adds to our mounting concerns." Following this downgrade, the Company's stock price fell $17.88 per share, or more than 10%, to close at $148.55 per share on March 23, 2022.

Next Steps: If you acquired shares of Okta, Inc. (OKTA) securities between March 5, 2021 and March 22, 2022, you have until July 19, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Okta, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:OKTA

Release Summary
Okta, Inc. (OKTA) Failed to Disclose Security Breach
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom